Universal Display Corporation — Q2 2023 Form 10-Q Summary
Business Context and Reporting Period
Universal Display Corporation develops and commercializes OLED technologies, phosphorescent OLED materials, intellectual property licenses and related services. Revenue is generated primarily from OLED material sales, royalty and license fees, and contract research services through Adesis. The unaudited filing covers the three and six months ended June 30, 2023, compared with the corresponding 2022 periods.
Financial Highlights
| Metric | Q2 2023 | Q2 2022 | Six Months 2023 | Six Months 2022 |
|---|---|---|---|---|
| Revenue | $146.6 million | $136.6 million | $277.0 million | $287.0 million |
| Gross margin | $114.4 million | $109.3 million | $211.9 million | $226.6 million |
| Gross margin percentage | 78% | 80% | 76% | 79% |
| Operating income | $58.6 million | $53.3 million | $104.0 million | $115.6 million |
| Net income | $49.7 million | $41.5 million | $89.5 million | $91.5 million |
| Diluted EPS | $1.04 | $0.87 | $1.87 | $1.92 |
| Operating cash flow | Not separately provided | Not separately provided | $57.4 million | $86.1 million |
Q2 revenue increased 7.3%, operating income increased 10.0%, and net income increased 19.7% year over year. Six-month revenue declined 3.5%, operating income declined 10.0%, and net income declined 2.1%.
- Q2 material sales were $77.1 million, up 7%; unit material volume increased 9%.
- Q2 royalty and license fees were $64.4 million, up 7%.
- Q2 contract research services revenue was $5.1 million, up 15%; six-month revenue was $10.1 million, up 21%.
- Research and development expense increased 15% in Q2 and 16% for the six-month period.
- Interest income increased to $6.2 million in Q2 and $13.2 million for the six-month period, primarily because of higher investment yields and investment balances.
Liquidity, Cash Flow, Debt and Capital Allocation
- At June 30, 2023, cash and cash equivalents were $93.5 million, short-term investments were $465.7 million, and long-term corporate and U.S. Government bond investments were approximately $197.3 million, totaling approximately $756.5 million.
- Working capital was $797.4 million, compared with $763.8 million at December 31, 2022.
- Six-month operating cash flow was $57.4 million, compared with $86.1 million in the prior-year period. The decline primarily reflected working-capital outflows, including increases in accounts receivable and decreases in deferred revenue and accrued liabilities.
- Investing cash flow was negative $17.5 million, including $27.3 million of property and equipment purchases and $66.1 million for acquired intangible assets, partly offset by investment maturities and sales.
- Financing cash flow was negative $39.9 million, including $33.4 million of dividends and $7.4 million of employee tax withholding payments.
- The filing does not disclose outstanding borrowings or traditional funded debt. Lease liabilities totaled $31.0 million on a present-value basis, and the Company had no finance leases.
- The Board declared a third-quarter dividend of $0.35 per share on August 1, 2023.
Material Changes Versus the Prior Comparable Period
- Six-month material sales declined 7%, with unit volume down 6%, primarily because of weaker OLED-market demand in the first quarter amid unfavorable macroeconomic conditions. Management described the weakness as potentially temporary, but the timing of recovery remains uncertain.
- Q2 demand improved, with material sales and unit volumes increasing year over year.
- Gross margin percentage declined because of higher per-unit material costs, excess inventory reserves and underutilization of the Shannon, Ireland manufacturing facility.
- Shannon underutilization charges were $3.9 million in Q2 and $8.6 million for the six-month period. Management expects near-term underutilization while capacity is brought online for anticipated future growth.
- Inventory reserves increased by $4.1 million in the first six months, compared with $0.7 million in the prior-year period, due to excess inventory in certain products.
- On April 28, 2023, the Company acquired more than 550 OLED-related patents and applications from Merck KGaA for $66.0 million. The acquired technology is being amortized over 10 years.
- On June 15, 2023, shareholders approved a new equity compensation plan, with 1.5 million shares available for future grants at June 30, 2023.
Guidance, Outlook, Risks and Unusual Items
Management did not provide specific numerical revenue or earnings guidance in the filing. It expects the Shannon facility to remain underutilized in the near term while preparing for anticipated growth and states that market recovery timing remains uncertain.
- Customer concentration is significant: four customers represented 85% of Q2 revenue and 85% of six-month revenue. Approximately 98% of Q2 revenue and 97% of six-month revenue came from outside North America.
- The Company relies substantially on one supplier for chemical materials and has $27.6 million of inventory purchase commitments at June 30, 2023.
- The Company had $23.9 million of committed phosphorescent emitter material backlog expected to be fulfilled within 90 days.
- A Korean tax refund claim remains pending. The Company recorded a $59.1 million long-term tax receivable related to Korean withholding taxes and a $15.0 million long-term U.S. tax liability associated with anticipated tax-return amendments. Outcomes and timing remain uncertain.
- The Company has an unfunded supplemental executive retirement plan liability of $60.7 million and eight participants as of June 30, 2023.
- Patent opposition and review proceedings may affect the scope or validity of patent claims. The filing states that no material changes occurred to previously disclosed risk factors.
- Management expects existing cash, cash equivalents and short-term investments to fund obligations for at least the next 12 months, while noting that future research, development, patent and commercialization needs could require additional financing.
Most Important Facts for Investors to Verify
- Whether the Q2 improvement in OLED material demand continues and offsets the first-quarter volume decline.
- The pace at which Shannon manufacturing capacity is utilized and whether underutilization charges decline.
- The sustainability of revenue concentration among major customers and the effect of customer production levels on royalties and material purchases.
- The recoverability and timing of the $59.1 million Korean tax receivable and related U.S. tax obligations.
- The economic contribution and amortization impact of the $66.0 million Merck KGaA patent acquisition.
- Inventory levels, reserve trends and the effect of excess inventory on future gross margins.
- Future cash requirements for capital expenditures, research and development, patent activities, dividends and potential financing.